Back to EGRX

EAGLE PHARMACEUTICALS, INC. 8-K

Accession 0001104659-20-034363

Filing information

CIK
0000827871
Report date
2020-03-17
Filing date
2020-03-17
Form
8-K
Primary document
tm2012833-1_8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.